166 related articles for article (PubMed ID: 35050467)
1. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
[TBL] [Abstract][Full Text] [Related]
3. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
[TBL] [Abstract][Full Text] [Related]
4. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
[TBL] [Abstract][Full Text] [Related]
5. Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.
Rokutan-Kurata M; Yoshizawa A; Ueno K; Nakajima N; Terada K; Hamaji M; Sonobe M; Menju T; Date H; Morita S; Haga H
J Thorac Oncol; 2021 Oct; 16(10):1753-1758. PubMed ID: 33905897
[TBL] [Abstract][Full Text] [Related]
6. The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
J Surg Oncol; 2023 Jan; 127(1):174-182. PubMed ID: 36098331
[TBL] [Abstract][Full Text] [Related]
7. EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
Nomura K; Aokage K; Kaminuma Y; Nakai T; Wakabayashi M; Ikeno T; Koike Y; Taki T; Miyoshi T; Tane K; Samejima J; Ishii G; Tsuboi M
Int J Clin Oncol; 2024 Mar; 29(3):248-257. PubMed ID: 38319510
[TBL] [Abstract][Full Text] [Related]
8. Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.
Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
J Thorac Oncol; 2019 Feb; 14(2):245-254. PubMed ID: 30336325
[TBL] [Abstract][Full Text] [Related]
9. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics.
Cho IS; Shim HS; Lee HJ; Suh YJ
Lung Cancer; 2023 Oct; 184():107345. PubMed ID: 37611496
[TBL] [Abstract][Full Text] [Related]
11. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
[TBL] [Abstract][Full Text] [Related]
12. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
Hou L; Wang T; Chen D; She Y; Deng J; Yang M; Zhang Y; Zhao M; Zhong Y; Ma M; Zhao G; Chen Y; Xie D; Zhu Y; Chen Q; Wu C; Chen C;
Mod Pathol; 2022 Jun; 35(6):749-756. PubMed ID: 35013526
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
[TBL] [Abstract][Full Text] [Related]
15. Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management.
Mikubo M; Tamagawa S; Kondo Y; Hayashi S; Sonoda D; Naito M; Shiomi K; Ichinoe M; Satoh Y
Lung Cancer; 2024 Jan; 187():107445. PubMed ID: 38157805
[TBL] [Abstract][Full Text] [Related]
16. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.
Kadota K; Yeh YC; Sima CS; Rusch VW; Moreira AL; Adusumilli PS; Travis WD
Mod Pathol; 2014 May; 27(5):690-700. PubMed ID: 24186133
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System.
Fujikawa R; Muraoka Y; Kashima J; Yoshida Y; Ito K; Watanabe H; Kusumoto M; Watanabe SI; Yatabe Y
J Thorac Oncol; 2022 May; 17(5):700-707. PubMed ID: 35227909
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].
Ding FG; Liu B; Zhang XH; Xu Y; Yu B; Zhang RS; He Y; Ma HH; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):145-50. PubMed ID: 22800475
[TBL] [Abstract][Full Text] [Related]
20. Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.
Park BJ; Woo W; Cha YJ; Shim HS; Yang YH; Moon DH; Kim BJ; Kim HE; Kim DJ; Paik HC; Lee JG; Lee S; Lee CY
Lung Cancer; 2023 Jan; 175():1-8. PubMed ID: 36436241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]